The broad impact of RA signaling on growth and differentiation has led to targeting RAR actions for the prevention and/or treatment of several different cancers (16), but RA bioavailability and RAR isotype expression levels and functionality vary greatly among different cell types. The gene discussed is RARA; the disease is cancer.